Cite
Glioblastoma-Derived Exosomes as Nanopharmaceutics for Improved Glioma Treatment.
MLA
Lee, Hyeji, et al. “Glioblastoma-Derived Exosomes as Nanopharmaceutics for Improved Glioma Treatment.” Pharmaceutics, vol. 14, no. 5, May 2022, p. 1002. EBSCOhost, https://doi.org/10.3390/pharmaceutics14051002.
APA
Lee, H., Bae, K., Baek, A.-R., Kwon, E.-B., Kim, Y.-H., Nam, S.-W., Lee, G. H., & Chang, Y. (2022). Glioblastoma-Derived Exosomes as Nanopharmaceutics for Improved Glioma Treatment. Pharmaceutics, 14(5), 1002. https://doi.org/10.3390/pharmaceutics14051002
Chicago
Lee, Hyeji, Kanghye Bae, Ah-Rum Baek, Eun-Bin Kwon, Yeoun-Hee Kim, Sung-Wook Nam, Gang Ho Lee, and Yongmin Chang. 2022. “Glioblastoma-Derived Exosomes as Nanopharmaceutics for Improved Glioma Treatment.” Pharmaceutics 14 (5): 1002. doi:10.3390/pharmaceutics14051002.